About the journal

Basic information

 

The journal Revista Peruana de Medicina Experimental y Salud Pública (RPMESP) is the official publication for science diffusion of the Instituto Nacional de Salud (INS), Lima, Perú; it is a quarterly journal whose objective is the publication of scientific production in the biomedical social context, in order to participate in the improvement of the health situation of the country and the region.

RPMES publishes articles on biomedical and public health topics; and facilitates exchange with similar entities in Peru and abroad, to promote research application and scientific experience in health.

Edited first in October 1942, with the name of Revista de Medicina Experimental, since the year 2002 it keeps the actual denomination.

The short title is Rev Peru Med Exp Salud Publica, which should be used in bibliography, footnotes, references and blbliographical legends.

 

 

Indexing sources

 
  • Index Medicus / U.S. National Library of Medicine – MEDLINE.
  • Database of Abstracts and Citations for Scholarly Journal Articles – SCOPUS.
  • Scientific Electronic Library Online Salud Publica, Bireme, Brasil – SciELO Salud Pública.
  • Directory of Open Access Journal – DOAJ.
  • Red de Revistas Científicas de América Latina y El Caribe, España y Portugal - RedALyC
  • Scientific Electronic Library Online – SciELO Perú.
  • Health Internet Network Access to Research Initiative – HINARI.
  • Academic Search Complete – Grupo EBSCO.
  • Excerpta Medica Database / Elsevier B.V. – EMBASE.
  • Índice Mexicano de Revistas Biomédicas Latinoamericanas – IMBIOMED.
  • Sistema Regional de Información en Línea para Revistas Científicas en América Latina, El Caribe, España y Portugal – LATINDEX.
  • Literatura Latino-Americana e do Caribe em Ciências da Saúde – LILACS.
  • Red Panamericana de Información en Salud Ambiental – REPIDISCA.
  • Literatura Peruana en Ciencias de la Salud – LIPECS.
  • Acceso Libre a Información Científica para la Innovación (CONCYTEC) – ALICIA.
 

 

Intellectual Property

 

All content of the journal, except where noted, is licensed under a Creative Commons license of type BY.

 

 

Sponsors

 

The journal is exclusively funded by:

All rights are reserved by the Instituto Nacional de Salud.

Any publication, diffusion or distribution of the presented information is authorized as long as the original source is cited.

The papers don't necessarily express the journal´s opinion, being the authors responsible for the statements they issue.

 


Editorial Board

Editors

 
  • Director

Zuño Burstein Alva
Instituto Nacional de Salud - INS. Lima, Perú.
rpmesp@gmail.com

  • Editor in Chief

César Cabezas Sánchez
Instituto Nacional de Salud - INS. Lima, Perú.
ccabezas@ins.gob.pe

  • Scientific Editor

Alonso Soto Tarazona
Hospital Nacional Hipólito Unanue - HNIU. Lima, Perú.
sotosolari@gmail.com

 

 

Associated Editors

 
  • Hugo Arroyo Hernández

Instituto Nacional de Salud - INS. Lima, Perú.
rpmesp@gmail.com

  • J. Jhonnel Alarco

Instituto Nacional de Salud - INS. Lima, Perú.
rpmesp@gmail.com

  • Rubén Borja García

Instituto Nacional de Salud - INS. Lima, Perú.
rpmesp@gmail.com

 

 

Editorial Committee

 
  • Walter H. Curioso Vílchez

Universidad Peruana Cayetano Heredia - UPCH. Lima, Perú.
walter.curioso@upch.pe

  • Alfredo Guillén Oneeglio

Universidad Nacional Federico Villarreal - UNFV. Lima, Perú.
alfredo_guillen@yahoo.com

  • César Gutiérrez Villafuerte

Universidad Nacional Mayor de San Marcos - UNMSM. Lima, Perú.
cesar.gutierrez@udep.pe

  • Percy Mayta Tristan

Universidad Científica del Sur - UCS. Lima, Perú.
p.mayta@gmail.com

  • Edward Mezones Holguín

Instituto Nacional de Salud - INS. Lima, Perú.
emezones@gmail.com

  • J. Jaime Miranda Montero

Universidad Peruana Cayetano Heredia - UPCH. Lima, Perú.
mirandajj@gmail.com

  • Alberto Perales Cabrera

Universidad Nacional Mayor de San Marcos - UNMSM. Lima, Perú.
perales.alberto@gmail.com

  • Oswaldo Salaverry García

Instituto Nacional de Salud - INS. Lima, Perú.
oswaldosalaverry@gmail.com

  • Lely Solari Zerpa

Instituto Nacional de Salud - INS. Lima, Perú.
lelysol@hotmail.com

  • Javier Vargas Herrera

Universidad Nacional Mayor de San Marcos - UNMSM. Lima, Perú.
jrrv@hotmail.com

  • Gisely Hijar Guerra

Instituto Nacional de Salud - INS. Lima, Perú.
giselins@gmail.com

  • Franco Romaní Romaní

Instituto Nacional de Salud - INS. Lima, Perú.
fromanir@gmail.com

  • Juan Pablo Aparco Balboa

Instituto Nacional de Salud - INS. Lima, Perú.
japarco@ins.gob.pe

  • Luz María Moyano Vidal

Universidad Peruana Cayetano Heredia - UPCH. Lima, Perú.
luz.moyano.v@upch.pe

  • Enrique Velásquez Hurtado

Ministerio de Desarrollo e Inclusión Social – MIDIS. Lima, Perú.
jvelasquez@midis.gob.pe

  • Fredy Canchihuamán Rivera

Universidad Peruana Cayetano Heredia - UPCH. Lima, Perú.
fcanchihuaman@ins.gob.pe

  • Marina Piazza Ferrand

Instituto Nacional de Salud - INS. Lima, Perú.
mpiazza@ins.gob.pe

 

 

Advisory council

 
  • Renato Alarcón Guzmán
    Academia Nacional de Medicina, Perú.
  • Jorge Alarcón Villaverde
    Universidad Nacional Mayor de San Marcos, Perú.
  • Werner Apt Baruch
    Universidad de Chile, Chile.
  • Javier Arias-Stella
    Academia Nacional de Medicina, Perú.
  • Alessandro Bartoloni
    Universita’ di Firenze, Italia.
  • Carlos Cáceres Palacios
    Universidad Peruana Cayetano Heredia, Perú.
  • Heriberto Fernández Jaramillo
    Universidad Austral de Chile, Chile.
  • Héctor H. García Lescano
    Instituto Nacional de Ciencias Neurológicas, Perú.
  • Patricia J. García Funegra
    Universidad Peruana Cayetano Heredia, Perú.
  • Uriel García Cáceres
    Academia Nacional de Medicina, Perú.
  • Fausto Garmendia Lorena
    Universidad Nacional Mayor de San Marcos, Perú.
  • Gustavo Gonzáles Rengifo
    Universidad Peruana Cayetano Heredia, Perú.
  • Eduardo Gotuzzo Herencia
    Universidad Peruana Cayetano Heredia, Perú.
  • Humberto Guerra Allison
    Universidad Peruana Cayetano Heredia, Perú.
  • Roger Guerra-García
    Academia Nacional de Ciencias, Perú.
  • Heinner Guio Chunga
    Instituto Nacional de Salud, Perú.
  • Luis Haro García
    Universidad Nacional Autónoma de México, México.
  • Daniel Haro Haro
    Academia Peruana de Cirugía, Perú.
  • Gilberto Henostroza Haro
    Universidad Peruana Cayetano Heredia, Perú.
  • Jay Kaufman
    McGill University, Canada.
  • Michael Knipper
    Justus Liebig Universität Giessen, Alemania.
  • Claudio Lanata de las Casas
    Instituto de Investigación Nutricional, Perú.
  • Víctor Alberto Laguna Torres
    Ministerio de Salud, Perú.
  • Alejandro Llanos Cuentas
    Universidad Peruana Cayetano Heredia, Perú.
  • Ciro Maguiña Vargas
    Universidad Peruana Cayetano Heredia, Perú.
  • Germán Málaga Rodríguez
    Hospital Nacional Cayetano Heredia, Perú.
  • Paulo Marchiori Buss
    Fundación Oswaldo Cruz - Fiocruz, Brasil.
  • David Moore
    London School of Hygiene and Tropical Medicine, Reino Unido.
  • Sergio Muñoz Navarro
    Universidad de la Frontera, Chile.
  • César G. Náquira Velarde
    Universidad Nacional Mayor de San Marcos, Perú.
  • Oscar Pamo Reyna
    Universidad Peruana Cayetano Heredia, Perú.
  • Graciela Risco de Dominguez
    Universidad Tecnológica del Perú, Perú.
  • Alfonso J. Rodríguez Morales
    Universidad Tecnológica de Pereira, Colombia.
  • Victor Suárez Moreno
    Instituto Nacional de Salud, Perú.
  • Aníbal Velásquez Valdivia
    Universidad Nacional Mayor de San Marcos, Perú.
  • Armando Yarlequé Chocas
    Universidad Nacional Mayor de San Marcos, Perú
  • Juan Mendoza Vega
    Academia Nacional de Medicina, Colombia.
  • Nelson Morales Soto
    Academia Nacional de Medicina, Perú.
  • Pilar Mazzetti Soler
    Instituto Nacional de Ciencias Neurológicas, Perú.
  • Eduardo Pretell Zárate
    Universidad Peruana Cayetano Heredia, Perú.
  • Lucía Llosa Isenrich
    Universidad Peruana Cayetano Heredia, Perú.
  • Fernando Llanos Zavalaga
    Ministerio de Desarrollo e Inclusión Social, Perú.
  • Juan E. Mezzich
    New York University, EE UU.
  • Mauricio Hernández Ávila
    Instituto Nacional de Salud Pública, México.
  • Félix Rosenberg
    Fundación Oswaldo Cruz – Fiocruz, Brasil.
  • Peter Cherutich
    Ministry of Health, Kenya.
  • Stephen S. Gloyd
    University of Washington, EE UU.
  • Michael Marmot
    University College London, Reino Unido.
  • César Munayco Escate
    Uniformed Services University of Health Sciences, EEUU.
  • Shahul H. Ebrahim
    Centers for Disease Control, EE UU.
  • Sean Hennessy
    University of Pennsylvania, EE UU.
  • Chaeshin Chu
    Korea Centers for Disease Control and Prevention, Korea.
  • Carla Sáenz
    Organización Panamericana de la Salud, EE UU.
  • Oswaldo Zegarra Rojas
    Academia Nacional de Medicina, Perú.
  • Ziad Memish
    Ministry of Health, Reino de Arabia Saudita.
  • Gabriel Rabinovich
    Instituto de Biología y Medicina Experimental, Argentina.
  • Timothy O’Connor
    University of Maryland, EE UU.
  • Alberto Davila
    Fundación Oswaldo Cruz – Fiocruz, Brasil.
  • Axel Kroeger
    Organización Mundial de la Salud, Suiza.
  • James C. Anthony
    Michigan State University, EE UU.
  • Silvia Runge Ranzinger
    Organización Mundial de la Salud, Suiza.
  • Bernat Soria
    Centro Andaluz de Biología Molecular y Medicina Regenerativa, España.
  • Juan R. Tejedo
    Universidad Pablo de Olavide, España.
 

 

Editorial Production

 
  • Editorial assistant

Bertha Huarez Sosa - INS. Lima, Perú.
bertha.huarez@gmail.com

  • Copyeditor

Daniel Cárdenas Rojas - INS. Lima, Perú.
dcardenas.ins@gmail.com

  • Administrative Coordinador

Jimmy Carreazo Pariasca - INS. Lima, Perú.
jcarreazo@ins.gob.pe

 

 


Instructions to authors

Objective and policy

 

The Revista Peruana de Medicina Experimental y Salud PUblica (RPMESP) is the official unit of scientific diffusion for the National Institute of Health (INS) of Peru.  It is a publication arbitrated by peers, published quarterly, with global scope and reach, and indexed in MEDLINE/Index Medicus, Scopus, EMBASE, SciELO Public Health and other international databases. The RPMESP is distributed in print and electronic versions, with free access to full text.

The RPMESP publishes articles on topics of interest in experimental medicine or public health, highlighting practical contributions to help improve the health situation of the country and the region. These articles must not have been previously published in whole or in part, or sent simultaneously to other journals, in any language.

Instructions for the journal are based on the "Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals" from the "International Committee of Medical Journal Editors' ICMJE. The types of articles included in the RPMESP are the following: Editorial, Original Articles, Brief Original, Review, Special Section, Symposium, History of Public Health, Case Reports, Photo Gallery, and Letters to Editor.

EDITORIAL PROCESS

INITIAL EVALUATION OF THE RPMESP EDITORIAL COMMITTEE

Registered papers will be presented and offered for consideration by the Editorial Board of the RPMESP, which consists of a multidisciplinary team of expert members from leading research institutions. The Editorial Committee shall determine if the item may pass on to the peer review process, otherwise it will be returned to the author.

PEER REVIEW

Peer review seeks to ensure the quality of the articles published. Research papers are evaluated by two or more reviewers who are selected according to their expertise on the subject, proven by their publications and academic degrees. Also, there is support of independent experts in biostatistics and epidemiology that focus on the methodological aspects of the studies. In all cases, the participation of the reviewers is anonymous and ad honorem.

The rating of the reviewers can be: a) publication of the paper without any modifications, b) publishable with minor modifications, which are recommendations for the improvement of the article; c) significant modifications, whose response is critical before accepting the publication of the article; d) recommendation to not publish the article. For original articles, the reviewers may suggest that the article is to be published as a Brief Report.

In light of the comments of the reviewers, the Editorial Committee will decide on the publication of the article, its non-acceptance or submission of comments to the author.

RESPONSE TO COMMENTS

The author must send the corrected article and with tracked changes in a separate document, with an answer to each of the comments received. The comments by the reviewers and the Editorial Committee of the RPMESP must be resolved and/or duly supported for the decision to publish the article. The RPMESP may re-submit the corrected article to a reviewer before considering its publication.

The average time of the editorial process, which includes the receipt of the article until the final decision of the Editorial Committee of the RPMESP varies from two to four months, depending on the response speed of our reviewers and the authors.

PROOFS

Approved items undergo an editing process, where authors can make changes, eliminate or add text, tables and figures, all of which will be presented to the authors for final approval. If the authors do not make comments to the proof within the deadline set by the Editorial Board, the article will be accepted by the RPMESP as the final version.

ETHICAL CONSIDERATIONS IN RESEARCH AND PUBLICATION

RESEARCH ETHICS

The RPMESP attains the current standards of ethics in research and scientific publication. When research in humans is presented, authors must mention if the procedures respected ethical standards consistent with the Declaration of Helsinki (updated to 2013) and whether they were approved by an Institutional Review Board.

The journal requires approval of an Institutional Review Board for: 1) Research in human beings; 2) Research that directly uses human biological materials or data capable of identifying humans such as biobank samples or medical records.

The journal does not require approval of an Institutional Review Board for: 1) studies using secondary databases which are publicly available, including systematic reviews, meta-analysis and bibliometric studies; 2) Interventions of public health surveillance; 3) Investigation of outbreaks or health emergencies; 4) Assessments of public health programs.

Doubts and/or controversies will be evaluated and resolved by the Editorial Board of the RPMESP as stated previously. All must comply with the following standards and international bodies: Declaration of Helsinki 2013, World Health Organization - WHO, The Council for International Organization of Medical Science – CIOMS, American College Of Epidemiology Ethics Guidelines, Health Research Ethics Authority – Canada.

PUBLICATION ETHICS

In cases where an ethical fault is detected either during review or after publication, the RPMESP will take the necessary measures based on the recommendations of the Committee on Publication Ethics (www.publicationethics.org.uk), which may include the refusal or withdrawal of the article, the ban of all authors of the article in coming issues of the RPMESP, notification to other journals, as well as communication with the relevant authorities (home institution, institution that funded the study, professional institutions and ethics committees).

The most common forms of ethical lapses in publication are: plagiarism, fictitious or honorary authorship, data manipulation and attempts to duplicate or re-publish data.

Authors are invited to establish a process of dialogue and transparency through seamless communication and request additional information regarding any concerns on these issues by contacting the RPMESP editorial team in the emails listed above.

AUTHORSHIP CRITERIA

The attribution of authorship in the RPMESP is based on the recommendations of the ICMJE:

1) Significant contributions to the conception and design of the manuscript, or the collection, analysis or interpretation of data;
2) Writing or major critical review of the manuscript content;
3) Final approval of the version to be published, and
4) The assumption of responsibility for all aspects of the manuscript, to ensure that matters relating to the accuracy or completeness of any part of it are properly investigated and resolved.

Authors must meet the four conditions mentioned. Also, the ICMJE states that the acquisition of funding, collection of data or general supervision of the research team does not justify authorship and those persons should be listed in the acknowledgments section.

 

 

Format and preparation of the manuscripts

 

STRUCTURE OF ARTICLES

1. FIRST PAGE

Must include:

Title; in Spanish and English (with a maximum of 15 words).
Short title: in Spanish and English (with a maximum of 5 words).
Identification of the authors:

- Full name of each of the authors. We will display only the first and last name, or both last names joined with a hyphen. If the authors wish to include other forms of presentation of their names, they should justify them.
- Institutional affiliation. Each author may include a maximum of two affiliations that include city and country.
- Career and academic degree. Each author should note their profession and their highest completed degree. Terms such as "candidate", "consultant", "teacher", "head of service" or "professor" are not accepted.

Authors' contributions. The manuscript must indicate the individual contributions of each author in the preparation of the article, as indicated in the "Application and list of authors".
Sources of funding. The manuscript must indicate whether the work was self-funded or funded by any institution.
Conflicts of Interest.  You must declare any relationship, condition or circumstance that may reduce objectivity in the interpretation of the article, which can be economic or institutional (consultancies, scholarships, payments for travel, per diem, etc.). For more information, please review the form Updated ICMJE Conflict of Interest Reporting Form (www.icmje.org/conflicts-of-interest/)
Correspondence. Indicate the name, address, telephone and email of the corresponding author.

If the research has been presented at a scientific meeting or as part of a thesis or technical report, authors should place the corresponding reference below the title.

2. ARTICLE BODY

The manuscript should be in Microsoft Word®, in A4 page size, using 10 point "Arial" font, and single-spaced. The manuscript should include a call out for figures and tables, which should be attached in separate files.
Abstract. Original articles should be structured as follows: objectives, materials and methods, results and conclusions. Brief Originals must present this information but without subtitles. For other types of articles, the abstract is unstructured.
Key words. The manuscript must include a minimum of three and a maximum of five key words in Spanish and English. Authors should use "health sciences descriptors" from BIREME (http://DeCS.bvs.br/) for key words in Spanish and MeSH NLM (http://nlm.nih.gov/mesh/) for key words in English.

The maximum length of words according to the type of article is shown in Table 1.

Table 1. Maximum length of words, tables, figures and references according to section.

Section

Abstract

Content

Figures and tables

Bibliographical references

Editorial*

--

1500

--

5

Original article

250

3500

6

30

Brief original

150

2000

4

20

Case reports

150

1500

5

15

Review

250

4000

5

70

Symposium*

250

4000

4

30

Special section

150

2500

3

30

History of Public Health*

100

2500

3

30

Photo gallery

--

800

12

10

Letter to editor

--

500/1000

1

5

* Section requested by the Director of the RPMESP.
In the case of systematic reviews, it is possible to accept a greater number of bibliographical references.
A thousand words will be allowed in preliminary investigations.

3. BIBLIOGRAPHIC REFERENCES

Only bibliographic references cited in the text and ordered correlatively in order of appearance should be included in the bibliography. Vancouver format should be used in accordance with the rules of the "Uniform Requirements for Manuscripts submitted to Biomedical Journals" ICMJE (http://www.nlm.nih.gov/bsd/uniform_requirements.html). In the case of more than six authors, the first six followed by "et al." should be used. Also, the title of the reference should include a hyperlink directed to the web site where the reference can be accessed, provided there is a corresponding electronic version.

4. TABLES AND FIGURES

Each table or figure should be attached to individual files and in their original format. A reference to all tables and figures included in the attachment must be made in the body of the article.

Tables: must be ordered in Arabic numerals and contain all necessary information including a complete title that can be interpreted without referring to the text. The journal only accepts one horizontal line, used to separate the header from the body of the table, and in no case will include vertical lines. Tables should be in Word or Excel. The meaning for all abbreviations and symbols should be explained at the bottom of the table.

Figures: Figures are considered to be maps, photographs, diagrams or charts, and must be ordered with Arabic numerals. TIFFs or JPGs at a resolution of 600 dpi or 300 pixels are accepted. The figures must be presented in a format that can be edited. The legends of photomicrographs should indicate the magnification and staining method. Maps should also have a scale. In figures showing faces of patients, place a dark band covering the eyes to obscure identification of the patient. The authors must attach the written consent of the patient or his/her legal representative consenting to the publication of the photos. If a previously published figure is used, indicate the source of origin and submit written permission from the owner of the copyright.

5. CONSIDERATIONS OF STYLE

The journal uses the International System of Units. Scientific names of species should be placed in italics. Titles of manuscripts should not use abbreviations. At first mention in the body of the text, the term should be spelled out, followed by the abbreviation in parentheses. Thereafter, only the abbreviation should be used. When referring to several authors in the body of the manuscript, indicate the last name of the first author, followed by "et al.". (e.g., Cabezas, et al.).

SPECIFIC INSTRUCTIONS FOR EACH TYPE OF ARTICLE

1. EDITORIAL

Presented at the request of the director of the RPMESP, editorials should refer to articles published in the same number of the issue, particularly for a symposium, or address a topic of interest according to editorial policy.

2. ORIGINAL ARTICLE

These are research articles that develop a topic of interest for the journal that are solid, original, current and timely. They must have the following structure: abstract, keywords, introduction, materials and methods, results, discussion and references. The maximum length is 250 words for the abstract, 3,500 words for the content, six tables or figures, and thirty references.

Abstract structure: Objectives, Materials and Methods, Results and Conclusions. In Spanish and English.
Key words. The manuscript must propose a minimum of three and a maximum of five key words in Spanish or English. The "health sciences descriptors" from BIREME (http://DeCS.bvs.br/) and MeSH (https://www.ncbi.nlm.nih.gov/mesh) should be used.
Introduction. Brief summary of the current state of the problem, background, rationale and objectives of the study.
Materials and methods. Describe the methodology used in order to allow reproduction of the study and evaluation of the quality of the information. The type and design of research, population characteristics and sample selection method must be described. In some cases, it may be appropriate to describe the study area. Detail the procedures performed. If they have been previously described, include the corresponding citations. Specify the measurement or definition procedures of the variables of interest. Mention the statistical procedures used. When medicinal plants are used, the procedures for the recollection and identification of the plants must be described. Identify drugs and chemical compounds used, with their generic names, doses and routes of administration. Authors can use subtitles for ease of presentation. Authors are encouraged to review the international consensus for specific types of articles such as STROBE guidelines for observational studies; CONSORT for clinical trials; STARD for diagnostic tests, PRISMA for meta-analyses, etc. Guides and useful information for the presentation of articles can be found on the EQUATOR website (www.equator-network.org). Ethical considerations involved in the study must be described. If the study involves humans or animals, the manuscript must mention that all required international ethical standards were met. For studies involving humans, identify the Institutional Review Board that approved the protocol. The Editorial Committee may request the approval records by the Ethics Committee and the informed consent for the study to be published. The Editorial Board will require the approval of the study by an institutional ethics committee in cases described in section III "Ethical considerations in research and publication."
Results. Present results clearly, without including opinions or interpretations, except in those of a statistical nature. Results can be supplemented by tables and figures, which should not repeat the information presented in the text. Results can include subtitles for ease of presentation.
Discussion. The discussion interprets the results, compares these results with the findings of other authors, and presents the inferences of the author. Limitations and potential bias of the study should be included, as well as the strengths, and closing with conclusions and recommendations.
Acknowledgements. When appropriate, mention specifically who and why the type of collaborative research was done to support the acknowledgement.
Bibliographic references. Authors must have the bibliographic references previously mentioned in the content of the article according to the specifications mentioned in point II. 3.

3. BRIEF ORIGINALS

Brief Originals are research articles which due to their objectives, design and results can be published in abbreviated form. They must have the following structure: unstructured abstract, keywords, Introduction, Study (including methodology), Findings (describing results), Discussion and References. The maximum length is 150 words for the abstract, 2,000 words for the content, four figures or tables, and twenty references.

4. REVIEW

Reviews should be conducted by experts in the field. They should include a thorough, objective and systematic exploration of current information on a particular topic of interest in experimental medicine or public health. Reviews must have the following structure: unstructured abstract, keywords, introduction, body of the article, conclusions and references. The maximum length is 250 words in the abstract, 4,000 words in the content, five figures or tables, and seventy references.

5. SYMPOSIUM

These are a set of structured articles on a topic approved by the Editorial Board of the RPMESP and led by a Guest Editor, who proposes the authors. The theme and orientation of the articles will be coordinated with the Guest Editor for the edition. Symposium have the following structure: unstructured abstract, keywords, body of the article, and references. The maximum length is 250 words in the abstract, 4,000 words in the content, four figures or tables, and thirty references.

6. SPECIAL SECTION

The Special Section includes articles that are within the editorial policy of the journal that do not conform to the characteristics of other sections. This includes essays, opinions, systematizations and experiences that are of interest to public health. No items that promote institutions, products, people or have conflicts of interest will be accepted for publication. These manuscripts have the following structure: unstructured abstract, keywords, body of the article, and references. The maximum length is 150 words in the abstract, 2,500 words in the content, three figures or tables, and thirty references.

7. CASE REPORT

Cases presented must be of diseases or conditions of public health interest. They are to have the following structure: unstructured abstract, keywords, introduction, case report, discussion (where the contribution or teaching is highlighted) and references. The maximum length is 150 words in the abstract, 1,500 words in the body, five figures or tables and fifteen references. Patients are to be identified by a sequential number, authors will not use patient initials or clinical chart numbers from the hospital or institutional records, nor will they include any information on the basis of which the identity of the patient(s) could be known. Illustrations and/or photos must be described in detail. In the reproduction of microscopic preparations, authors must explain the enlargement and staining methods. At the foot of the legends, include the meaning of all abbreviations used.

8. HISTORY OF PUBLIC HEALTH

This section includes articles on the history of public health including biographical notes on people who have made ​​an outstanding contribution to public health or experimental medicine. These articles have the following structure: unstructured abstract, keywords, body of the article and references. The maximum length is 100 words in the abstract, 2,500 words in the content, three figures or tables, and thirty references.

9. PHOTO GALLERY

These articles contain photos of interest for their uniqueness or novelty of a health issue, accompanied by a brief commentary on the theme and an explanation of the origin of the photos presented. The word limit is 800 and has a maximum of twelve figures and ten references. Figures must be accompanied by an explanatory legend. Editorial Board of the RPMESP reserves the right to limit the number of photos.

10. LETTER TO EDITOR

This section is open to all readers of RPMESP. Authors send contributions to supplement or discuss articles published in the last two issues of the RPMESP as well as new and relevant points of view on issues of public health, ethics or medical education. Letters to the editor can have up to three authors and a maximum of 500 words. The editorial policy of the Journal allows authors to make a reply to reviewers’ comments. Results of preliminary investigations or interventions for outbreaks that have not been published or submitted for publication in another journal can be published. Letters to the Editor may have up to 1,000 words and one table or figure. These cases will be subject to review by a peer reviewer. Letters should not be divided into sections but should include a problem statement, discussion, and conclusion with recommendations.

 

 

Manuscript Submission

 

Manuscript submissions should be uploaded to http://www.rpmesp.ins.gob.pe after subscribing as an author.
                               
REQUIRED DOCUMENTATION

It is mandatory that the corresponding author submits:

1) An application and list of authors, properly completed and following the proper format;
2) A manuscript written according to the instructions in this document.

We recommend that authors consider the following aspects to track articles sent to the RPMESP:

- Make an acknowledgment to each communication.
- A communication of receipt and the proof will be sent to each of the authors.
- The corresponding author of the article may be consulted at any time regarding the progress of the article's revisions, and the review times outlined in the "editorial process" should be considered.
- If a response to the comments is not received in five weeks, the item will be removed from the editorial process.

- Please send any questions to rpmesp@gmail.com or call +511 7481111 Annex 2122.

 
Instituto Nacional de Salud Lima - Lima - Peru
E-mail: revmedex@ins.gob.pe